<- Go Home

Siemens Healthineers AG

Siemens Healthineers AG, through its subsidiaries, develops, manufactures, and sells a range of diagnostic and therapeutic products and services to healthcare providers in Germany, the United States, rest of Europe, CIS, Africa, the Middle East, the Americas, the Asia Pacific, Japan, and China. It operates in four segments: Imaging, Diagnostics, Varian, and Advanced Therapies. The Imaging segment offers magnetic resonance imaging, computed tomography, X-ray, molecular imaging, and ultrasound systems; and software solutions to support the reading and structured reporting of diagnostic images from different modalities. Its Diagnostics segment provides in-vitro diagnostic products and services to healthcare providers in the fields of general and specialty laboratory, and point-of-care diagnostics; and workflow solutions for laboratories and informatics products. The Varian segment offers microwave, cryoablation, and embolization technologies, as well as clinical professional services for cancer care that support oncology departments in hospitals and clinics; and customized support for cancer care operations. Its Advanced Therapies segment provides products that are designed to support image-guided minimally invasive clinical procedures in various areas, such as cardiology, neurology, and oncology; angiography systems and mobile C-arms; and AI-powered clinical applications. It also offers essential technical customer service, such as maintenance and repair; spare parts; medical equipment performance management; training; clinical education and e-learning; planning and design; financing; asset management; and managed departmental services for laboratories and healthcare facilities, as well as healthcare consulting, products, and services. The company was founded in 1896 and is headquartered in Forchheim, Germany. Siemens Healthineers AG is a subsidiary of Siemens Aktiengesellschaft.

Market Cap

EUR 47.5B

Volume

931.1K

Cash and Equivalents

EUR 2.1B

EBITDA

EUR 4.0B

Tax Rate Collected

N/A

Tax Rate Ratio

N/A

Gross Profit

EUR 9.0B

Profit Margin

38.44%

52 Week High

EUR 58.48

52 Week Low

EUR 40.97

Dividend

N/A

Price / Book Value

2.59

Price / Earnings

22.54

Price / Tangible Book Value

-9.39

Enterprise Value

EUR 60.1B

Enterprise Value / EBITDA

14.14

Operating Income

EUR 3.1B

Return on Equity

11.19%

Return on Assets

4.25

Cash and Short Term Investments

EUR 2.1B

Debt

EUR 14.7B

Equity

EUR 18.5B

Revenue

EUR 23.3B

Unlevered FCF

EUR 2.4B

Sector

Health Care Equipment and Supplies

Category

N/A

Hedge Funds that own this stock

PREMIUM

Upgrade to Yellowbrick Premium to unlock the Professional Funds that own this company (and many other perks).

Upgrade to Yellowbrick Premium

Yellowbrick Portfolios that own this stock

PREMIUM

Upgrade to Yellowbrick Premium to unlock the Yellowbrick portfolios that own this company (and many other perks).

Upgrade to Yellowbrick Premium

Company Stock Pitches